Physician profile
Tracy Elder
NPI 1437705522
$906.75
in general payments reported to CMS, 2019-2025
19 companies · $17.73 in 2025
The $17.73 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $320 · 2023: $514 · 2024: $55.24 · 2025: $17.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.04 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.56 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $73.91 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $57.01 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.81 | 2023 | Xifaxan |
| Dexcom, INC. | $48.31 | 2022-2023 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $39.25 | 2023 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $38.84 | 2022-2023 | Breztri |
| Tris Pharma INC | $31.22 | 2023 | Dyanavel Xr |
| Biohaven Pharmaceutical Holding Company Ltd. | $28.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.78 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.57 | 2022 | |
| Shield Therapeutics INC | $21.62 | 2022 | |
| Ironshore Pharmaceuticals INC. | $21.18 | 2023 | Jornay Pm |
| Radius Health, INC. | $20.13 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $14.82 | 2022 | |
| Phadia US INC. | $13.80 | 2023 | Immunocap |
| Nestle Healthcare Nutrition INC. | $13.40 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.